Key result
Diabetic patients treated with insulin or oral hypoglycaemic agents had increased 7-year mortality post-MI compared to non-diabetic patients.
Why the study?
Does the presence of diabetes and its specific treatment regimen affect long-term mortality in patients with acute myocardial infarction?
Cohort (n=6,676)
Does the presence of diabetes and its specific treatment regimen affect long-term mortality in patients with acute myocardial infarction?
Diabetic patients with acute myocardial infarction, particularly those requiring insulin or oral hypoglycemic agents, receive less thrombolysis and have significantly higher long-term mortality compared to non-diabetic patients.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in diabetic MI survivors; hypothesis-generating for therapy-specific effects on long-term survival.
AIMS: The present study was performed to evaluate pre-admission history, presentation, initial treatment and long-term mortality in patients with myocardial infarction and diabetes. METHODS AND RESULTS: Between 1990 and 1992, 6676 patients with acute myocardial infarction were screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. In this cohort 719 (11%) of the patients had a history of diabetes. Among the diabetic patients 19% were treated with insulin, 52% with oral hypoglycaemic agents and 29% with diet only. The diabetic patients were slightly older, more likely to be female and had a higher prevalence of known cardiovascular disease. Even though the diabetic patients had the same frequency of ST-segment elevation on the electrocardiogram and the same admission delay, treatment with thrombolysis and aspirin was less frequently prescribed to the diabetic patients than to patients without diabetes. The mortality rate was significantly increased in the diabetic patients, 7-year mortality being 79% in insulin-treated, 73% in tablet-treated and 62% in diet-treated diabetic patients compared with 46% in patients without diabetes. In a multivariate analysis only diabetic patients treated with oral hypoglycaemic agents or with insulin had an increased mortality compared with non-diabetic patients. CONCLUSIONS: Patients with diabetes mellitus and myocardial infarction are treated with thrombolysis to a lesser extent than non-diabetic patients. Diabetic patients treated with oral hypoglycaemic agents or insulin, but not those treated with diet alone, have a significantly increased mortality following acute myocardial infarction compared with non-diabetic patients.
No takes yet. Share an insight, caveat, or question.
Finn Gustafsson (2000) conducted a cohort in Acute myocardial infarction and diabetes (n=6,676). Antidiabetic treatment regimens (insulin, oral hypoglycaemic agents, diet only) vs. Patients without diabetes was evaluated on 7-year mortality. Diabetic patients treated with insulin or oral hypoglycaemic agents had increased 7-year mortality post-MI compared to non-diabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: